![]() |
Volumn 368, Issue 10, 2013, Pages 886-889
|
When to start ART in Africa - An urgent research priority
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
AFRICA;
CD4 LYMPHOCYTE COUNT;
CLINICAL RESEARCH;
DISEASE TRANSMISSION;
EPIDEMIC;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INCIDENCE;
INFECTION;
INFECTION PREVENTION;
LOWEST INCOME GROUP;
MIDDLE INCOME GROUP;
MORBIDITY;
MORTALITY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RISK REDUCTION;
SHORT SURVEY;
TREATMENT INDICATION;
TUBERCULOSIS;
VIRUS LOAD;
VIRUS TRANSMISSION;
|
EID: 84874742048
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp1300458 Document Type: Article |
Times cited : (62)
|
References (5)
|